• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛的阿育吠陀疗法——病例报告

Ayurveda management of migraine - a case report.

作者信息

Patil Giramalla, Patil Shivanand, Hosur Prateek

机构信息

All India Institute of Ayurveda, Sarita Vihar, New Delhi, 110076, India.

All India Institute of Ayurveda, Dargalim, Goa, 403519, India.

出版信息

J Ayurveda Integr Med. 2024 Sep-Oct;15(5):100983. doi: 10.1016/j.jaim.2024.100983. Epub 2024 Oct 24.

DOI:10.1016/j.jaim.2024.100983
PMID:39454285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11539406/
Abstract

Migraine is one of the most prevalent causes of functional disability worldwide. Migraine patients experience headaches of varying degrees, which are related with a higher level of disability and are triggered by psychological and physiological stressors. Migraine is estimated to affect 16.6% of the world's population, with women being three times more likely to experience it than men. Despite considerable advancements in modern and traditional medicine, a complete cure remains uncertain. In Ayurvedic treatises, migraine headache is referred to as Ardhavabedhaka under the classification of Shiroroga (diseases related to the head region). 35-year-old Indian male police inspector, suffering from recurrent right hemi-cranial headaches once in three days for the last three months, presented symptoms of Tridhoshaja Ardhvabhedaka (Migraine) associated with Amlapitta (hyperacidity). After a thorough assessment of the patient, the treatment was meticulously planned based on the patient's Dosha pradhanyatha and Vyadhi avastha(stage of disease). For the proper Samprapti vighatana, Nidana parivarjana (abstinance from the eitiological factors), Deepana, Paachana, Siravyadha, Nasya and Dosha ShamanaChikitsa principles were adopted. Further, the severity of the migraine was assessed by MIDAS and NPR score, which subsequently decreased from 19 to 4, and the NPR scale decreased from 8 to 2 till completion of the therapeutic intervention. This case report unequivocally highlights the pivotal role of the Ayurveda treatment regimen in effectively managing migraine. Overall, effective treatment of migraine cases requires the correct assessment of Dosha status and Vyadhi avastha and the correct selection of the appropriate medicine and procedures like Siravyadha and Nasya at that appropriate stage of the disease.

摘要

偏头痛是全球导致功能残疾的最常见原因之一。偏头痛患者会经历不同程度的头痛,这与更高水平的残疾相关,且由心理和生理应激源引发。据估计,偏头痛影响着全球16.6%的人口,女性患偏头痛的可能性是男性的三倍。尽管现代医学和传统医学都取得了显著进展,但完全治愈仍不确定。在阿育吠陀论著中,偏头痛在头病(与头部区域相关的疾病)分类下被称为半侧头痛。一名35岁的印度男性警察检查员,在过去三个月里每隔三天就会出现一次复发性右半侧头痛,表现出与胃酸过多相关的三体液型半侧头痛(偏头痛)症状。在对患者进行全面评估后,根据患者的体液主导情况和疾病阶段精心制定了治疗方案。为了正确阻断发病过程,采用了避免病因、开胃、消食、通脉、滴鼻和调节体液等治疗原则。此外,通过偏头痛残疾评定量表(MIDAS)和数值疼痛评分(NPR)对偏头痛的严重程度进行评估,随后该评分从19降至4,NPR量表从8降至2,直至治疗干预结束。本病例报告明确强调了阿育吠陀治疗方案在有效管理偏头痛方面的关键作用。总体而言,有效治疗偏头痛病例需要正确评估体液状态和疾病阶段,并在疾病的适当阶段正确选择合适的药物和治疗方法,如通脉和滴鼻。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087e/11539406/618eb1e83609/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087e/11539406/14fb364c0d54/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087e/11539406/618eb1e83609/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087e/11539406/14fb364c0d54/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/087e/11539406/618eb1e83609/gr2.jpg

相似文献

1
Ayurveda management of migraine - a case report.偏头痛的阿育吠陀疗法——病例报告
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):100983. doi: 10.1016/j.jaim.2024.100983. Epub 2024 Oct 24.
2
A pilot study on clinical efficacy of and decoction (an Ayurvedic formulation) in the management of (migraine).一项关于[具体名称]汤(一种阿育吠陀配方)治疗[具体疾病](偏头痛)临床疗效的试点研究。 (注:原文中部分内容缺失,以上是根据现有内容尽量完整翻译)
Ayu. 2018 Jan-Mar;39(1):56-61. doi: 10.4103/ayu.AYU_84_17.
3
Eleven years of disease free survival in a case of Invasive Ductal Carcinoma (IDC) Rt Breast grade 3, stage 3, treated with add on Ayurveda treatment: A case report.11年无病生存的右乳浸润性导管癌(IDC)3级、3期病例,采用阿育吠陀辅助治疗:病例报告
J Ayurveda Integr Med. 2024 Jan-Feb;15(1):100881. doi: 10.1016/j.jaim.2023.100881. Epub 2024 Feb 1.
4
Ayurveda for management of migraine: A narrative review of clinical evidence.阿育吠陀疗法治疗偏头痛:临床证据的叙述性综述
J Family Med Prim Care. 2022 Aug;11(8):4228-4235. doi: 10.4103/jfmpc.jfmpc_2109_21. Epub 2022 Aug 30.
5
A double-blind controlled clinical trial to evaluate the effects of nasal therapy with Vrihatajivakadya oil on different viscosities in patients with migraine.一项双盲对照临床试验,以评估使用Vrihatajivakadya油进行鼻腔治疗对偏头痛患者不同黏度的影响。
J Ayurveda Integr Med. 2023 Mar-Apr;14(2):100662. doi: 10.1016/j.jaim.2022.100662. Epub 2022 Nov 13.
6
Ayurvedic management of idiopathic small fibre neuropathy- A case report.阿育吠陀疗法治疗特发性小纤维神经病变——病例报告
J Ayurveda Integr Med. 2023 Mar-Apr;14(2):100708. doi: 10.1016/j.jaim.2023.100708. Epub 2023 May 2.
7
Management of Nasya-induced pyrexia in a patient with refractive error and migraine: a case report.屈光不正和偏头痛患者中纳氏疗法诱发发热的管理:一例报告。
J Ayurveda Integr Med. 2023 Nov-Dec;14(6):100812. doi: 10.1016/j.jaim.2023.100812. Epub 2023 Nov 29.
8
Headache Education Active-Waiting Directive: A Program to Enhance Well-Being During Long Referral Wait Times.头痛教育主动等待指令:一个在长时间转诊等待期间增强幸福感的项目。
Headache. 2018 Jan;58(1):109-117. doi: 10.1111/head.13194. Epub 2017 Nov 12.
9
Impact of Erenumab on Migraine Disability: A Three-Month MIDAS (Migraine Disability Assessment Scale) Score Analysis at Dubai Health Facilities.erenumab对偏头痛残疾的影响:迪拜医疗机构的三个月偏头痛残疾评定量表(MIDAS)评分分析
Cureus. 2024 Aug 18;16(8):e67113. doi: 10.7759/cureus.67113. eCollection 2024 Aug.
10
Need for care and perceptions of MIDAS among headache sufferers study.头痛患者对MIDAS的护理需求及认知研究。
CNS Drugs. 2002;16 Suppl 1:5-11. doi: 10.2165/00023210-200216001-00002.

本文引用的文献

1
Ayurvedic Treatment Protocol for Hereditary Pancreatitis: A Case Report Demonstrating Disease Arrestation.遗传性胰腺炎的阿育吠陀治疗方案:一例疾病得到控制的病例报告
Cureus. 2023 Aug 2;15(8):e42876. doi: 10.7759/cureus.42876. eCollection 2023 Aug.
2
Ayurvedic management of idiopathic small fibre neuropathy- A case report.阿育吠陀疗法治疗特发性小纤维神经病变——病例报告
J Ayurveda Integr Med. 2023 Mar-Apr;14(2):100708. doi: 10.1016/j.jaim.2023.100708. Epub 2023 May 2.
3
Protocol based pain management by Ayurveda parasurgical procedures W.S.R to musculoskeletal pain and its critical appraisal - An open labeled clinical trial.
基于阿育吠陀辅助手术程序的疼痛管理方案(针对肌肉骨骼疼痛)及其批判性评估——一项开放标签临床试验
J Ayurveda Integr Med. 2022 Oct-Dec;13(4):100665. doi: 10.1016/j.jaim.2022.100665. Epub 2022 Nov 24.
4
Ayurveda for management of migraine: A narrative review of clinical evidence.阿育吠陀疗法治疗偏头痛:临床证据的叙述性综述
J Family Med Prim Care. 2022 Aug;11(8):4228-4235. doi: 10.4103/jfmpc.jfmpc_2109_21. Epub 2022 Aug 30.
5
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家310种疾病和损伤的发病率、患病率及伤残调整生命年:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
6
Molluscum contagiosum: A novel Ayurvedic approach.传染性软疣:一种新颖的阿育吠陀疗法。
Anc Sci Life. 2013 Jul;33(1):49-51. doi: 10.4103/0257-7941.134606.
7
Evaluation of anti-secretory and anti-ulcerogenic activities of avipattikar churna on the peptic ulcers in experimental rats.阿魏帕蒂卡尔 churnam 对实验性大鼠消化性溃疡的抗分泌和抗溃疡活性评估。
J Clin Diagn Res. 2013 Jun;7(6):1135-9. doi: 10.7860/JCDR/2013/5309.3058. Epub 2013 Jun 1.
8
An analysis of migraine triggers in a clinic-based population.基于临床人群的偏头痛诱因分析。
Headache. 2010 Sep;50(8):1366-70. doi: 10.1111/j.1526-4610.2010.01753.x.
9
Response to Ayurvedic therapy in the treatment of migraine without aura.阿育吠陀疗法对无先兆偏头痛的治疗反应。
Int J Ayurveda Res. 2010 Jan;1(1):30-6. doi: 10.4103/0974-7788.59941.
10
Can we conquer pain?我们能战胜疼痛吗?
Nat Neurosci. 2002 Nov;5 Suppl:1062-7. doi: 10.1038/nn942.